original ) (raw )Evaluation of the adherence to subcutaneous immunotherapy in patients with pollen allergy in usual clinical practice: The CITY study
Begona Soler
Trends in Medicine
View PDFchevron_right
Adherence issues related to sublingual immunotherapy as perceived by allergists
Michele Schiappoli
2010
View PDFchevron_right
A survey on the perception of allergy specialists about the reimbursed grass pollen tablets for seasonal allergic rhinitis in Italy
Cristoforo Incorvaia
Clinical and molecular allergy : CMA, 2017
View PDFchevron_right
Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
Massimo Milani
2013
View PDFchevron_right
A Multicenter, Randomized, Parallel-Group Trial Assessing Compliance, Tolerability, Safety, and Efficacy to Treatment with Grass Allergy Tablets in 261 Patients with Grass Pollen Rhinoconjunctivitis
Massimo Milani
Journal of Allergy, 2012
View PDFchevron_right
Optimal dose, efficacy, and safety of once-daily sublingual immunotherapy with a 5–grass pollen tablet for seasonal allergic rhinitis
margitta worm
Journal of Allergy and Clinical Immunology, 2007
View PDFchevron_right
Sublingual versus subcutaneous immunotherapy: patient adherence at a large German allergy center
Ralph Mösges
Patient Preference and Adherence, 2017
View PDFchevron_right
Sublingual grass allergen specific immunotherapy: a retrospective study of clinical outcome and discontinuation
Mary Kämpe
Clinical and Molecular Allergy
View PDFchevron_right
Maintenance dosing for sublingual immunotherapy by prominent European allergen manufacturers expressed in bioequivalent allergy units
Daniel Maddox
Annals of Allergy, Asthma & Immunology, 2011
View PDFchevron_right
Evidence of adherence to allergen-specific immunotherapy
Moises Domingo Pablo Calderon
Current Opinion in Allergy & Clinical Immunology, 2009
View PDFchevron_right
Implementation of pre-seasonal sublingual immunotherapy with a five-grass pollen tablet during optimal dosage assessment
margitta worm
Clinical & Experimental Allergy, 2009
View PDFchevron_right
Quantitative assessment of the compliance with once-daily sublingual immunotherapy in children (EASY project: evaluation of a novel SLIT formulation during a year)
Mario Di Gioacchino
Pediatric allergy and immunology : official publication of the European Society of Pediatric Allergy and Immunology, 2007
View PDFchevron_right
An observational cohort study of the use of five-grass-pollen extract sublingual immunotherapy during the 2015 pollen season in France
Pascal Demoly
Allergy, asthma, and clinical immunology : official journal of the Canadian Society of Allergy and Clinical Immunology, 2018
View PDFchevron_right
Efficacy of Grass Pollen Allergen Sublingual Immunotherapy Tablets for Seasonal Allergic Rhinoconjunctivitis
Antonella Plaia
JAMA Internal Medicine, 2015
View PDFchevron_right
Satisfaction and quality of life of allergic patients following sublingual five-grass pollen tablet immunotherapy in Spain
Carlos Poot blanco
Drugs in context, 2017
View PDFchevron_right
Early onset of action of a 5-grass-pollen 300-IR sublingual immunotherapy tablet evaluated in an allergen challenge chamber
Michel Melac
Journal of Allergy and Clinical Immunology, 2009
View PDFchevron_right
Budget impact analysis of two immunotherapy products for treatment of grass pollen-induced allergic rhinoconjunctivitis
Jakob Andreasen
ClinicoEconomics and Outcomes Research, 2012
View PDFchevron_right
Pharmacoeconomics of sublingual immunotherapy with the 5-grass pollen tablets for seasonal allergic rhinitis
Cristoforo Incorvaia
Clinical and molecular allergy : CMA, 2017
View PDFchevron_right
Health and economic impact of subcutaneous allergen immunotherapy in patients with pollen-induced allergic rhinoconjunctivitis: real-word evidence from the Czech Republic
Jan Tužil
Immunotherapy, 2022
View PDFchevron_right
Compliance with allergen immunotherapy and factors affecting compliance among patients with respiratory allergies
Waleed Al-herz
Human Vaccines & Immunotherapeutics, 2016
View PDFchevron_right
Ways to increase adherence to allergen immunotherapy
Constantinos Pitsios
Current Medical Research and Opinion, 2018
View PDFchevron_right
Allergen immunotherapy as a drug: the new deal of grass allergen tablets from clinical trials to current practice
carlo lombardi
European annals of allergy and clinical immunology, 2013
View PDFchevron_right
Efficacy and safety of 5-grass pollen sublingual immunotherapy tablets in patients with different clinical profiles of allergic rhinoconjunctivitis
Giampiero Patriarca
Clinical & Experimental Allergy, 2009
View PDFchevron_right
Sublingual immunotherapy tablet: a cost-minimizing alternative in the treatment of tree pollen-induced seasonal allergic rhinitis in Canada
Remi Gagnon
Allergy, Asthma & Clinical Immunology, 2021
View PDFchevron_right
Magnitude of efficacy measurements in grass allergy immunotherapy trials is highly dependent on pollen exposure
Harold Nelson
Allergy, 2014
View PDFchevron_right
Towards evidence-based medicine in specific grass pollen immunotherapy
Ralph Mösges
Allergy, 2010
View PDFchevron_right
Methodological aspects of a meta-analysis of grass pollen allergen sublingual immunotherapy tablets
Pascal Demoly
The Journal of allergy and clinical immunology, 2016
View PDFchevron_right
Clinical management, expectations, and satisfaction of patients with moderate to severe allergic rhinoconjunctivitis treated with SQ-standardized grass-allergen tablet under routine clinical practice conditions in Spain
carlos cruz puerto
Clinical and molecular allergy : CMA, 2017
View PDFchevron_right
Sublingual grass allergen tablet immunotherapy provides sustained clinical benefit with progressive immunologic changes over 2 years
ronald dahl
Journal of Allergy and Clinical Immunology, 2008
View PDFchevron_right
Sublingual or subcutaneous immunotherapy for seasonal allergic rhinitis: an indirect analysis of efficacy, safety and cost
Anne Ellis
Journal of Evaluation in Clinical Practice, 2014
View PDFchevron_right